celastrol has been researched along with Triple Negative Breast Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, M; Huang, G; Liu, Z; Ma, L; Xia, C; Xuan, X | 1 |
| Li, Z; Liu, L; Wu, Z; Yan, F | 1 |
| A Kim, S; Jeong, Y; Kim, S; Kim, SW; Lee, JE; Nam, SJ; Yoon, SY; You, D | 1 |
| Li, Q; Qian, Y; Shen, Q; Xu, R; Zhang, J; Zhu, G | 1 |
4 other study(ies) available for celastrol and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
Celastrol inhibits the migration and invasion and enhances the anti-cancer effects of docetaxel in human triple-negative breast cancer cells.
Topics: Cadherins; Cell Line, Tumor; Docetaxel; Humans; Pentacyclic Triterpenes; Triple Negative Breast Neoplasms | 2022 |
Celastrol Inhibits Migration and Invasion of Triple-Negative Breast Cancer Cells by Suppressing Interleukin-6 via Downregulating Nuclear Factor-κB (NF-κB).
Topics: Cell Line, Tumor; Cell Movement; Down-Regulation; Female; Humans; Interleukin-6; Neoplasm Invasiveness; NF-kappa B; Pentacyclic Triterpenes; Triple Negative Breast Neoplasms | 2020 |
Celastrol attenuates the inflammatory response by inhibiting IL‑1β expression in triple‑negative breast cancer cells.
Topics: Benzimidazoles; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Humans; Interleukin-1beta; MAP Kinase Signaling System; Neoplasm Invasiveness; Pentacyclic Triterpenes; Triple Negative Breast Neoplasms | 2021 |
Nanoparticles based on polymers modified with pH-sensitive molecular switch and low molecular weight heparin carrying Celastrol and ferrocene for breast cancer treatment.
Topics: Animals; Antineoplastic Agents; Benzimidazoles; beta-Cyclodextrins; Cell Line, Tumor; Cell Movement; Cell Survival; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Female; Ferrous Compounds; Heparin, Low-Molecular-Weight; Hydrogen-Ion Concentration; Metallocenes; Mice, Inbred BALB C; Nanoparticles; Neoplasm Invasiveness; Pentacyclic Triterpenes; Polyethyleneimine; Polylactic Acid-Polyglycolic Acid Copolymer; Reactive Oxygen Species; Stimuli Responsive Polymers; Triple Negative Breast Neoplasms; Tumor Burden | 2021 |